Best Performance Large Cap Stocks in 2015
The year to date performance of the benchmark S&P 500 index as of the writing of this article in Mid-May of 2015 was up a meager 1.9%. Stocks have chopped around in a large range as investors attempt to grasp a Federal Reserve that is likely to raise interest rates and a global macro environment where Europe and China are easing rates. Despite the lackluster returns, there have been a number of large cap stocks that have significantly outperform the market. Here is a list of the top 10, and why investors are trading them.
Synageva Biopharma Corp (GEVA): Bio-pharma and technology have been all the rage in 2015, with stocks soaring as much as 127.9%. Synageva BioPharma is a biopharmaceutical company focused on the discovery and commercialisation of therapeutic products for patients with rare diseases. The company has a rich pipeline of therapies for patients with rare diseases who have unmet medical needs. Investors are in this large cap stocks with the hopes that new products will bolster earnings as many continue to focus on rare diseases.
This content is restricted to site members. If you are an existing user, please log in. New users may register below for FREE.